REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 39 filers reported holding REDHILL BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $656,000 | -13.7% | 108,000 | 0.0% | 0.06% | -17.3% |
| Q3 2019 | $760,000 | +8.3% | 108,000 | 0.0% | 0.08% | +5.6% |
| Q2 2019 | $702,000 | -21.7% | 108,000 | 0.0% | 0.07% | +6.0% |
| Q1 2019 | $897,000 | +34.7% | 108,000 | -10.0% | 0.07% | +31.4% |
| Q4 2018 | $666,000 | -65.5% | 120,000 | -45.2% | 0.05% | -48.5% |
| Q3 2018 | $1,932,000 | +3.5% | 218,800 | 0.0% | 0.10% | +4.2% |
| Q2 2018 | $1,866,000 | – | 218,800 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BANK HAPOALIM BM | 136,012 | $1,470,000 | 0.33% |
| Family Management Corp | 37,750 | $408,000 | 0.28% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $4,551,000 | 0.18% |
| Migdal Insurance & Financial Holdings Ltd. | 397,410 | $4,296,000 | 0.10% |
| Orbimed Advisors | 564,900 | $6,107,000 | 0.06% |
| INGALLS & SNYDER LLC | 41,250 | $446,000 | 0.02% |
| MONETARY MANAGEMENT GROUP INC | 3,000 | $32,000 | 0.01% |
| Candriam S.C.A. | 71,267 | $770,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 10,870 | $118,000 | 0.01% |
| D.A. DAVIDSON & CO. | 44,000 | $475,000 | 0.01% |